ReviewFrontiers in immunology2022

Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer.

Prameela Kandra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.